Hestia Insight Inc. (HSTA) Stock
Hestia Insight Inc. delivers specialized strategic consulting and capital market advisory support, primarily catering to small to mid-sized businesses within the healthcare, biotech, and fintech sectors.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Hestia Insight Inc.
Hestia Insight Inc. delivers specialized strategic consulting and capital market advisory support, primarily catering to small to mid-sized businesses within the healthcare, biotech, and fintech sectors. The company's service portfolio also extends to healthcare management and patient-focused solutions. Moreover, Hestia Insight Inc. is involved in creating and analyzing healthcare technologies, specifically those related to neurological and psychiatric conditions. Completing its range of services, the firm provides management and assistance for medical supply sales, alongside comprehensive sales and marketing strategy and guidance. Formerly known as Luxshmi Investments, Inc., the company officially rebranded to Hestia Insight Inc. in May 2019. It operates from its headquarters in Las Vegas, Nevada.
Hestia Insight Inc. is headquartered in US.
Hestia Insight Inc. (HSTA) stock trades at $0.03 with a market capitalization of $921996. The stock is valued at a price-to-earnings (P/E) ratio of -1.18, price-to-book of -2.55, price-to-sales of 57.62. Over the past 52 weeks the stock has ranged between $0.02 and $0.12, and currently trades 75.0% below its 52-week high.
On profitability, Hestia Insight Inc. generates return on capital employed of 174.66%.
Official website: www.hestiainsight.com